Ranitidine works by reducing the amount of acid produced by the stomach. It is a histamine H2-receptor antagonist. This means it blocks the action of histamine, a natural substance that signals the stomach to produce acid [1]. By inhibiting these H2 receptors, ranitidine decreases both the volume and acidity of stomach secretions [1][2]. This mechanism helps to alleviate symptoms associated with excess stomach acid, such as heartburn and indigestion [2].
How does ranitidine's mechanism compare to other acid reducers?
Unlike proton pump inhibitors (PPIs) such as omeprazole or lansoprazole, which block the final step of acid production, ranitidine acts earlier in the process by preventing histamine from stimulating acid secretion [3]. While PPIs are generally more potent acid reducers, ranitidine can be effective for managing milder conditions and symptoms [3]. Antacids, on the other hand, neutralize existing stomach acid rather than reducing its production [4].
When is ranitidine typically prescribed?
Ranitidine has been prescribed to treat and prevent heartburn, upset stomach, and acid indigestion [2]. It was also used to treat conditions caused by too much stomach acid, such as peptic ulcers and gastroesophageal reflux disease (GERD) [2].
What led to the withdrawal of ranitidine products?
Concerns arose regarding the presence of N-nitrosodimethylamine (NDMA), a probable human carcinogen, in some ranitidine products [5]. Studies found that NDMA could form in ranitidine over time, even under normal storage conditions [5]. This led to voluntary recalls and subsequent market withdrawals of ranitidine medications [5][6].
Where can I find information on drug patents?
Information regarding drug patents, including expiration dates and related litigation, can be found on resources like DrugPatentWatch.com [7].